Brinker Capital Investments’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,589
Closed -$136K 2182
2025
Q3
$136K Sell
10,589
-2,234
-17% -$29.8K ﹤0.01% 2003
2025
Q2
$195K Buy
12,823
+2,368
+23% +$36.9K ﹤0.01% 1903
2025
Q1
$175K Buy
10,455
+51
+0.5% +$939 ﹤0.01% 1819
2024
Q4
$196K Sell
10,404
-11,037
-51% -$213K ﹤0.01% 1755
2024
Q3
$403K Sell
21,441
-1,527
-7% -$29.3K ﹤0.01% 1411
2024
Q2
$434K Sell
22,968
-1,455
-6% -$24.8K ﹤0.01% 1318
2024
Q1
$397K Sell
24,423
-880
-3% -$12.9K ﹤0.01% 1368
2023
Q4
$366K Buy
25,303
+652
+3% +$8.23K ﹤0.01% 1328
2023
Q3
$336K Sell
24,651
-1,626
-6% -$25.1K ﹤0.01% 1334
2023
Q2
$451K Sell
26,277
-2,259
-8% -$35K ﹤0.01% 1248
2023
Q1
$397K Sell
28,536
-1,943
-6% -$28.6K ﹤0.01% 1229
2022
Q4
$408K Buy
30,479
+2,882
+10% +$37.3K 0.01% 1046
2022
Q3
$329K Buy
27,597
+2,764
+11% +$39.3K 0.01% 1082
2022
Q2
$316K Buy
24,833
+4,356
+21% +$55.9K 0.01% 1147
2022
Q1
$265K Buy
20,477
+2,871
+16% +$37.9K ﹤0.01% 1269
2021
Q4
$279K Buy
+17,606
New +$301K ﹤0.01% 1276

Other funds holding SEM

Brinker Capital Investments's SEM Position: Q4 2025 in Review

Brinker Capital Investments sold out of Select Medical (SEM) in Q4 2025, closing a stake of 10,589 shares — an estimated $136K sold.

Brinker Capital Investments first reported a position in SEM in Q4 2021 and held it in 16 quarters. The position peaked at $451K in Q2 2023. 268 funds tracked by Wall St. Rank hold SEM as of Q4 2025.

  • Brinker Capital Investments reported no remaining Select Medical position as of Q4 2025 after selling out during the quarter.
  • Brinker Capital Investments sold 10,589 Select Medical shares in Q4 2025, an estimated $136K.
  • Brinker Capital Investments first reported a position in Select Medical in Q4 2021 and held it in 16 quarters.
  • Brinker Capital Investments's Select Medical position peaked at $451K in Q2 2023.
  • 268 funds tracked by Wall St. Rank held Select Medical as of Q4 2025.

Based on Brinker Capital Investments's 13F filing for Q4 2025, filed 12 Feb 2026.